Clinical Trial Update: Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of temozolomide and everolimus in patients with stage IV melanoma that cannot be surgically removed; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Afinitor (everolimus)
• Temodar (Temozolomide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2017-03-07